Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma.

[1]  O. Hadid,et al.  Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma. , 2014, The Cochrane database of systematic reviews.

[2]  Hodgkin Lymphoma.  NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines , 2014 .

[3]  B. Coldiron,et al.  AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. , 2012, Journal of the American Academy of Dermatology.

[4]  Kristian Thorlund,et al.  How to use an article reporting a multiple treatment comparison meta-analysis. , 2012, JAMA.

[5]  Kris Chang,et al.  Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. , 2012, The New England journal of medicine.

[6]  K. Jurczyszyn,et al.  The application of Levulan®-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[7]  J. Ioannidis,et al.  Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents. , 2011, Journal of clinical epidemiology.

[8]  L. Pablo,et al.  Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma , 2011, British Journal of Ophthalmology.

[9]  J. Ioannidis,et al.  Industry sponsorship and selection of comparators in randomized clinical trials , 2010, European journal of clinical investigation.

[10]  S. Thanos,et al.  Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[11]  P. W. Bowers,et al.  A comparative study of the effects of disposable and Volkmann spoon curettes in the treatment of basal cell carcinoma , 2009, The British journal of dermatology.

[12]  M. Chren,et al.  Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men , 2009, Cancer Causes & Control.

[13]  A. Oseroff,et al.  Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies , 2009, International journal of dermatology.

[14]  John P.A. Ioannidis,et al.  Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses , 2009, Canadian Medical Association Journal.

[15]  R. Dawe,et al.  Randomized Comparison of Mohs Micrographic Surgery and Surgical Excision for Small Nodular Basal Cell Carcinoma: Tissue‐Sparing Outcome , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[16]  Howard W. Rogers,et al.  A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. , 2009, Journal of the American Academy of Dermatology.

[17]  P. Parekh,et al.  Imiquimod 5% Cream as Adjunctive Therapy For Primary, Solitary, Nodular Nasal Basal Cell Carcinomas Before Mohs Micrographic Surgery: A Randomized, Double Blind, Vehicle‐Controlled Study , 2009, Dermatologic Surgery.

[18]  C. Dirksen,et al.  Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. , 2008, The Lancet. Oncology.

[19]  R. Dummer,et al.  A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up. , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[20]  P. Steijlen,et al.  Fractionated 5‐aminolaevulinic acid–photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial , 2008, The British journal of dermatology.

[21]  Rik Roelandts,et al.  Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. , 2008, European journal of dermatology : EJD.

[22]  Georgia Salanti,et al.  Evaluation of networks of randomized trials , 2008, Statistical methods in medical research.

[23]  Marek Vlk,et al.  Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma , 2008, Lasers in surgery and medicine.

[24]  S. Ibbotson,et al.  A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma , 2008, The Journal of dermatological treatment.

[25]  R. Marks,et al.  Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double‐blind, randomized, placebo‐controlled, parallel group, multicenter study , 2007, International journal of dermatology.

[26]  A. Oseroff,et al.  Basal cell and squamous cell skin cancers. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[27]  C. Garbe,et al.  A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. , 2007, Journal of the American Academy of Dermatology.

[28]  Menno A de Rie,et al.  Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. , 2007, Archives of dermatology.

[29]  S. Ibbotson,et al.  A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low‐risk nodular basal cell carcinoma , 2007, The British journal of dermatology.

[30]  P. Nelemans,et al.  Surgical Excision versus Curettage plus Cryosurgery in the Treatment of Basal Cell Carcinoma , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[31]  H. Williams,et al.  Interventions for basal cell carcinoma of the skin. , 2007, The Cochrane database of systematic reviews.

[32]  Henricus J C M Sterenborg,et al.  Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. , 2006, The Journal of investigative dermatology.

[33]  W. Sterry.  Guidelines: the management of basal cell carcinoma. , 2006, European journal of dermatology : EJD.

[34]  J. Spencer.  Pilot Study of Imiquimod 5% Cream as Adjunctive Therapy to Curettage and Electrodesiccation for Nodular Basal Cell Carcinoma , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[35]  C. Ferrándiz,et al.  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle‐controlled phase III study in Europe , 2005, The British journal of dermatology.

[36]  N. Smeets.  Little evidence available on treatments for basal cell carcinoma of the skin. , 2005, Cancer treatment reviews.

[37]  K. Aftergut,et al.  Candida Antigen in the Treatment of Basal Cell Carcinoma , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[38]  Désirée Ratner,et al.  Current concepts : Basal-cell carcinoma , 2005 .

[39]  S. González,et al.  5% Imiquimod Cream and Reflectance‐Mode Confocal Microscopy as Adjunct Modalities to Mohs Micrographic Surgery for Treatment of Basal Cell Carcinoma , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[40]  Carmen D Dirksen,et al.  Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial , 2004, The Lancet.

[41]  L. Golitz,et al.  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. , 2004, Journal of the American Academy of Dermatology.

[42]  C. Elmets,et al.  Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. , 2004, Archives of dermatology.

[43]  Jean-Jacques Grob,et al.  Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. , 2004, Archives of dermatology.

[44]  W. Sterry,et al.  Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low‐frequency dosing with and without occlusion , 2002, The British journal of dermatology.

[45]  K. Gross,et al.  Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. , 2002, Journal of the American Academy of Dermatology.

[46]  S. Shumack,et al.  Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. , 2002, Archives of dermatology.

[47]  D. Kuijpers,et al.  Basal Cell Carcinoma , 2002, American journal of clinical dermatology.

[48]  E. D. Smith,et al.  Cost of Nonmelanoma Skin Cancer Treatment in the United States , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[49]  N. Cox,et al.  British Association of Dermatologists , 2001 .

[50]  R. Marks,et al.  Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. , 2001, Journal of the American Academy of Dermatology.

[51]  N. Bendsoe,et al.  Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial , 2001, The British journal of dermatology.

[52]  M. Thissen,et al.  Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[53]  A. Aupérin,et al.  Evaluation of Cosmetic Results of a Randomized Trial Comparing Surgery and Radiotherapy in the Treatment of Basal Cell Carcinoma of the Face , 2000, Plastic and reconstructive surgery.

[54]  J. Moan,et al.  Photodynamic Therapy of Superficial Basal Cell Carcinoma with 5-Aminolevulinic Acid with Dimethylsulfoxide and Ethylendiaminetetraacetic Acid: A Comparison of Two Light Sources , 2000, Photochemistry and photobiology.

[55]  J. Taylor,et al.  A Pilot Study to Evaluate the Treatment of Basal Cell Carcinoma with 5‐Fluorouracil Using Phosphatidyl Choline as a Transepidermal Carrier , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[56]  K. Beutner,et al.  Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. , 1999, Journal of the American Academy of Dermatology.

[57]  Telfer Nr,et al.  Guidelines for the management of basal cell carcinoma. British Association of Dermatologists. , 1999 .

[58]  A. Cognetta,et al.  Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel. , 1997, Journal of the American Academy of Dermatology.

[59]  A. Aupérin,et al.  Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. , 1997, British Journal of Cancer.

[60]  R. Dawber,et al.  Cryosurgery in the Treatment of Basal Cell Carcinoma: Assessment of One and Two Freeze‐Thaw Cycle Schedules , 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[61]  D I McLean,et al.  Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. , 1995, Archives of dermatology.

[62]  M A Weinstock,et al.  Nonmelanoma skin cancer in the United States: incidence. , 1994, Journal of the American Academy of Dermatology.

[63]  D. M. Brown,et al.  The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma. , 1992, Journal of the American Academy of Dermatology.

[64]  D. Whiting,et al.  The effect of intralesional interferon gamma on basal cell carcinomas. , 1990, Journal of the American Academy of Dermatology.

[65]  V. L. Hall,et al.  Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. , 1986, Clinical radiology.